wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47995019-E7B62DBE-14DF-4F99-B47E-9A4A5A5CD837
Q47995019-E7B62DBE-14DF-4F99-B47E-9A4A5A5CD837
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47995019-E7B62DBE-14DF-4F99-B47E-9A4A5A5CD837
Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics.
P2860
Q47995019-E7B62DBE-14DF-4F99-B47E-9A4A5A5CD837
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47995019-E7B62DBE-14DF-4F99-B47E-9A4A5A5CD837
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
48144c804d1db00a1fc61d7c84ce91e4c2dd3d70
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus